Free Trial

NewGenIvf Group (NIVF) Competitors

$0.33 -0.01 (-2.46%)
(As of 12/20/2024 05:31 PM ET)

NIVF vs. MGRX, VSEE, ATPC, BGLC, ATIP, ACON, CMAX, BACK, GBNHF, and UPHL

Should you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Mangoceuticals (MGRX), Vsee Health (VSEE), Agape ATP (ATPC), BioNexus Gene Lab (BGLC), ATI Physical Therapy (ATIP), Aclarion (ACON), CareMax (CMAX), IMAC (BACK), Greenbrook TMS (GBNHF), and UpHealth (UPHL). These companies are all part of the "healthcare" industry.

NewGenIvf Group vs.

NewGenIvf Group (NASDAQ:NIVF) and Mangoceuticals (NASDAQ:MGRX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation.

In the previous week, Mangoceuticals had 1 more articles in the media than NewGenIvf Group. MarketBeat recorded 2 mentions for Mangoceuticals and 1 mentions for NewGenIvf Group. Mangoceuticals' average media sentiment score of 0.74 beat NewGenIvf Group's score of 0.17 indicating that Mangoceuticals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NewGenIvf Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Mangoceuticals
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

NewGenIvf Group and Mangoceuticals both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
NewGenIvf GroupN/AN/A
MangoceuticalsN/AN/A

NewGenIvf Group has a net margin of 0.00% compared to Mangoceuticals' net margin of -1,237.00%. NewGenIvf Group's return on equity of 0.00% beat Mangoceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
NewGenIvf GroupN/A N/A N/A
Mangoceuticals -1,237.00%-138.00%-118.88%

66.2% of NewGenIvf Group shares are owned by institutional investors. Comparatively, 56.7% of Mangoceuticals shares are owned by institutional investors. 31.8% of NewGenIvf Group shares are owned by company insiders. Comparatively, 39.3% of Mangoceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

NewGenIvf Group has higher revenue and earnings than Mangoceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewGenIvf Group$5.14M0.66$130KN/AN/A
Mangoceuticals$755K8.17-$9.21M-$5.79-0.43

NewGenIvf Group has a beta of -0.12, meaning that its share price is 112% less volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 2.09, meaning that its share price is 109% more volatile than the S&P 500.

Summary

NewGenIvf Group beats Mangoceuticals on 6 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NIVF vs. The Competition

MetricNewGenIvf Grouphealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$3.47M$1.91B$5.14B$9.08B
Dividend YieldN/A7.04%5.09%4.23%
P/E RatioN/A15.5790.0517.18
Price / Sales0.663.171,117.14116.99
Price / Cash9.619.7743.0437.86
Price / Book3.033.044.784.78
Net Income$130,000.00$69.56M$120.31M$225.60M
7 Day Performance4.98%-1.73%-1.92%-1.23%
1 Month Performance-38.68%-2.76%11.51%3.36%
1 Year PerformanceN/A-25.02%30.61%16.60%

NewGenIvf Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NIVF
NewGenIvf Group
0.4995 of 5 stars
$0.33
-2.5%
N/AN/A$3.47M$5.14M0.00N/AGap Down
MGRX
Mangoceuticals
1.1789 of 5 stars
$2.51
-1.2%
N/A-96.2%$6.25M$730,000.000.003News Coverage
Positive News
Gap Down
VSEE
Vsee Health
N/A$1.68
+5.0%
N/AN/A$6.05MN/A0.00N/ANews Coverage
ATPC
Agape ATP
N/A$1.45
-2.4%
N/A-88.5%$5.79M$1.43M0.0040Positive News
Gap Down
BGLC
BioNexus Gene Lab
N/A$0.30
+3.1%
N/A-61.5%$5.39M$9.26M0.0030Positive News
Gap Up
ATIP
ATI Physical Therapy
0.0621 of 5 stars
$0.75
+74.4%
N/A-61.4%$3.31M$699.02M0.005,600Gap Up
High Trading Volume
ACON
Aclarion
1.8597 of 5 stars
$0.17
+1.3%
$1.30
+682.7%
-97.8%$1.73M$80,000.000.007Gap Down
CMAX
CareMax
0.866 of 5 stars
$0.42
-26.2%
N/A-96.8%$1.61M$751.10M0.001,450Gap Down
BACK
IMAC
N/A$1.18
+6.3%
N/A-19.3%$1.36M$16.19M0.00180Earnings Report
News Coverage
GBNHF
Greenbrook TMS
N/A$0.02
+36.4%
N/AN/A$612,000.00$73.79M0.00430Gap Down
UPHL
UpHealth
N/A$0.00
+33.3%
N/A-99.8%$8,000.00$130M0.001,750Gap Down

Related Companies and Tools


This page (NASDAQ:NIVF) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners